Lets take a look at the study. 54 patient treated over less than 2 months. 37 given drug combination, 17 given placebo. 40% had 10% lung improvement. Why not match this blockbuster drug against placebo, why did they combine it with a drug that was already on the market. Why did they not have equal patients on placebo and on the drug. Why not have a bigger study group? This study is a load of crap and the FDA is gonna toss this thing out the door unless the next study fixes these things.